Miguel
Fernández de Sanmamed Gutiérrez
Consultor Médico
Josep
Tabernero Caturla
Publicaciones en las que colabora con Josep Tabernero Caturla (2)
2023
-
A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors
Science translational medicine, Vol. 15, Núm. 695, pp. eabp9229
2017
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97